Sapio sciences makes ai-native drug discovery seamless with nvidia bionemo

Baltimore--(business wire)--sapio sciences, the science-aware™ lab informatics platform, today announced the integration of the nvidia bionemo platform into the sapio lab informatics platform. this integration brings ai-driven computational drug discovery directly into sapio eln (electronic lab notebook), helping to streamline workflows and improve decision-making in drug discovery. with the bionemo platform, researchers can accelerate drug discovery by leveraging science-specific ai frameworks.
NVDA Ratings Summary
NVDA Quant Ranking